5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18277838 | USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING ATRIAL FIBRILLATION AND/OR FLUTTER | GZYBOWSKI, MICHAEL STANLEY | 1798 | Non-Final OA | Aug 18, 2023 |
| 18271573 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MENTAL AND/OR A BEHAVIOURAL DISORDER | WECKER, JENNIFER | 1797 | Non-Final OA | Jul 10, 2023 |
| 18267956 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MUSCULOSKELETAL AND/OR CONNECTIVE TISSUE DISEASE | PAPCIAK, SHARON M | 1657 | Non-Final OA | Jun 16, 2023 |
| 18039883 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING AN ANEMIA AND/OR A METABOLIC CONDITION RELATED TO THE NUTRITIONAL STATE AND/OR FLUID BALANCE OF THE BLOOD | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Jun 01, 2023 |
| 18011082 | METHOD FOR DETERMINING WHETHER A SUBJECT HAS A DISEASE OR CONDITION OR IS AT RISK OF DEVELOPING A DISEASE OR CONDITION | FRITCHMAN, REBECCA M | 1758 | Final Rejection | Dec 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial